tradingkey.logo
Markets
News
Analysis
Tools
Learn
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo

Caris Life Sciences Inc

CAI

29.500USD

+1.980+7.19%
Close 07/30, 16:00（ET）Quotes delayed by 15 min
8.20BMarket Cap
LossP/E TTM

Caris Life Sciences Inc

29.500

+1.980+7.19%
OverviewCompanyFinancials
Statements
Income Statement
Balance Sheet
Cash Flow Statement

Overview

Company

Financials

Statements

Income Statement

Balance Sheet

Cash Flow Statement

Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
---31.34M
Net income from continuing operations
---102.58M
Operating gains losses
--7.04M
Other non-cash items
--3.85M
Change in working capital
--13.32M
-Change in receivables
--7.91M
-Change in inventory
--2.06M
-Change in prepaid expenses
--2.47M
-Change in other current assets
--36.00K
Cash from non-recurring investing activities
Cash from operating activities
---31.34M
Investing cash flow
Net cash from continuing investing activities
--2.69M
Capital expenditures
--2.69M
Net cash flow from disposal of fixed assets
--2.69M
Net cash flow from investment products
--0.00
Cash from non-current investing activities
Net cash flow from investing activities
---2.69M
Financing cash flow
Cash flow from continuous financing activities
--1.28M
Net cash flow from debt Issuance/repayment
---22.00K
Net cash flow from common stock issuance/repurchase
---22.00K
Proceeds from stock option exercised by employees
--1.43M
Net cash flow from other financing activities
---105.00K
Net cash from non-recurrent financing activities
Net cash from financing activities
--1.28M
Net cash flow
Beginning cash balance
--68.03M
Current period cash flow changes
---32.74M
Effect of exchange rate changes
--4.00K
Ending cash balance
--35.29M
Free cash flow
---34.03M
Currency unit
USD
Audit opinions
--
KeyAI